Jackson Square Partners’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Jackson Square Partners's AGN Position: Q2 2018 in Review
Jackson Square Partners sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 1,993,874 shares — an estimated $336M sold.
Jackson Square Partners first reported a position in AGN in Q1 2015 and held it in 13 quarters. The position peaked at $1.28B in Q4 2015. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.
- Jackson Square Partners reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
- Jackson Square Partners sold 1,993,874 Allergan plc shares in Q2 2018, an estimated $336M.
- Jackson Square Partners first reported a position in Allergan plc in Q1 2015 and held it in 13 quarters.
- Jackson Square Partners's Allergan plc position peaked at $1.28B in Q4 2015.
- 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.
Based on Jackson Square Partners's 13F filing for Q2 2018, filed 13 Aug 2018.